ESOPAug 11, 2026, 04:43 PM
BridgeBio Oncology Awards 65,350 Stock Options to New Hires
AI Summary
BridgeBio Oncology Therapeutics (BBOT) announced it awarded inducement grants of non-qualified stock options on August 10, 2026, to two individuals hired in July 2026. The grants cover an aggregate of 65,350 shares of BBOT common stock, with an exercise price of $9.28 per share. These awards were made under BBOT’s 2025 Inducement Plan and will vest over approximately four years, subject to continued service.
Key Highlights
- BridgeBio Oncology awarded inducement grants to two new employees.
- Grants include non-qualified stock options for 65,350 shares of common stock.
- Exercise price for the options is $9.28 per share.
- Options vest 1/4 on the first anniversary, then in 36 equal monthly installments.
- Awards were granted under BBOT's 2025 Inducement Plan.
- Approved by the compensation committee as a material inducement for employment.
Price Impact
More from BBOT